Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
- T44.8X5DBillable
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
- T44.8X5SBillable
Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela
- T44.8X6ABillable
Underdosing of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
- T44.8X6DBillable
Underdosing of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
- T44.8X6SBillable
Underdosing of centrally-acting and adrenergic-neuron-blocking agents, sequela
- T44.905ABillable
Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
- T44.905DBillable
Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter
- T44.905SBillable
Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela
- T44.906ABillable
Underdosing of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
- T44.906DBillable
Underdosing of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter
- T44.906SBillable
Underdosing of unspecified drugs primarily affecting the autonomic nervous system, sequela
- T44.995ABillable
Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter
- T44.995DBillable
Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter
- T44.995SBillable
Adverse effect of other drug primarily affecting the autonomic nervous system, sequela
- T44.996ABillable
Underdosing of other drug primarily affecting the autonomic nervous system, initial encounter
- T44.996DBillable
Underdosing of other drug primarily affecting the autonomic nervous system, subsequent encounter
- T44.996SBillable
Underdosing of other drug primarily affecting the autonomic nervous system, sequela
- T45.0X5ABillable
Adverse effect of antiallergic and antiemetic drugs, initial encounter
- T45.0X5DBillable
Adverse effect of antiallergic and antiemetic drugs, subsequent encounter
- T45.0X5SBillable
Adverse effect of antiallergic and antiemetic drugs, sequela
- T45.0X6ABillable
Underdosing of antiallergic and antiemetic drugs, initial encounter
- T45.0X6DBillable
Underdosing of antiallergic and antiemetic drugs, subsequent encounter
- T45.0X6SBillable
Underdosing of antiallergic and antiemetic drugs, sequela
- T45.1X5ABillable
Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
- T45.1X5DBillable
Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
- T45.1X5SBillable
Adverse effect of antineoplastic and immunosuppressive drugs, sequela
- T45.1X6ABillable
Underdosing of antineoplastic and immunosuppressive drugs, initial encounter
- T45.1X6DBillable
Underdosing of antineoplastic and immunosuppressive drugs, subsequent encounter
- T45.1X6SBillable
Underdosing of antineoplastic and immunosuppressive drugs, sequela
- T45.2X5ABillable
Adverse effect of vitamins, initial encounter
- T45.2X5DBillable
Adverse effect of vitamins, subsequent encounter
- T45.2X5SBillable
Adverse effect of vitamins, sequela
- T45.2X6ABillable
Underdosing of vitamins, initial encounter
- T45.2X6DBillable
Underdosing of vitamins, subsequent encounter
- T45.2X6SBillable
Underdosing of vitamins, sequela
- T45.3X5ABillable
Adverse effect of enzymes, initial encounter
- T45.3X5DBillable
Adverse effect of enzymes, subsequent encounter
- T45.3X5SBillable
Adverse effect of enzymes, sequela
- T45.3X6ABillable
Underdosing of enzymes, initial encounter
- T45.3X6DBillable
Underdosing of enzymes, subsequent encounter
- T45.3X6SBillable
Underdosing of enzymes, sequela
- T45.4X5ABillable
Adverse effect of iron and its compounds, initial encounter
- T45.4X5DBillable
Adverse effect of iron and its compounds, subsequent encounter
- T45.4X5SBillable
Adverse effect of iron and its compounds, sequela
- T45.4X6ABillable
Underdosing of iron and its compounds, initial encounter
- T45.4X6DBillable
Underdosing of iron and its compounds, subsequent encounter
- T45.4X6SBillable
Underdosing of iron and its compounds, sequela
- T45.515ABillable
Adverse effect of anticoagulants, initial encounter
- T45.515DBillable
Adverse effect of anticoagulants, subsequent encounter
- T45.515SBillable
Adverse effect of anticoagulants, sequela
- T45.516ABillable
Underdosing of anticoagulants, initial encounter
- T45.516DBillable
Underdosing of anticoagulants, subsequent encounter
- T45.516SBillable
Underdosing of anticoagulants, sequela
- T45.525ABillable
Adverse effect of antithrombotic drugs, initial encounter
- T45.525DBillable
Adverse effect of antithrombotic drugs, subsequent encounter
- T45.525SBillable
Adverse effect of antithrombotic drugs, sequela
- T45.526ABillable
Underdosing of antithrombotic drugs, initial encounter
- T45.526DBillable
Underdosing of antithrombotic drugs, subsequent encounter
- T45.526SBillable
Underdosing of antithrombotic drugs, sequela
- T45.605ABillable
Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
- T45.605DBillable
Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
- T45.605SBillable
Adverse effect of unspecified fibrinolysis-affecting drugs, sequela
- T45.606ABillable
Underdosing of unspecified fibrinolysis-affecting drugs, initial encounter
- T45.606DBillable
Underdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter
- T45.606SBillable
Underdosing of unspecified fibrinolysis-affecting drugs, sequela
- T45.615ABillable
Adverse effect of thrombolytic drugs, initial encounter
- T45.615DBillable
Adverse effect of thrombolytic drugs, subsequent encounter
- T45.615SBillable
Adverse effect of thrombolytic drugs, sequela
- T45.616ABillable
Underdosing of thrombolytic drugs, initial encounter
- T45.616DBillable
Underdosing of thrombolytic drugs, subsequent encounter
- T45.616SBillable
Underdosing of thrombolytic drugs, sequela
- T45.625ABillable
Adverse effect of hemostatic drug, initial encounter
- T45.625DBillable
Adverse effect of hemostatic drug, subsequent encounter
- T45.625SBillable
Adverse effect of hemostatic drug, sequela
- T45.626ABillable
Underdosing of hemostatic drugs, initial encounter
- T45.626DBillable
Underdosing of hemostatic drugs, subsequent encounter
- T45.626SBillable
Underdosing of hemostatic drugs, sequela
- T45.695ABillable
Adverse effect of other fibrinolysis-affecting drugs, initial encounter
- T45.695DBillable
Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter
- T45.695SBillable
Adverse effect of other fibrinolysis-affecting drugs, sequela
- T45.696ABillable
Underdosing of other fibrinolysis-affecting drugs, initial encounter
- T45.696DBillable
Underdosing of other fibrinolysis-affecting drugs, subsequent encounter
- T45.696SBillable
Underdosing of other fibrinolysis-affecting drugs, sequela
- T45.7X5ABillable
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
- T45.7X5DBillable
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
- T45.7X5SBillable
Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
- T45.7X6ABillable
Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter
- T45.7X6DBillable
Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter
- T45.7X6SBillable
Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela
- T45.8X5ABillable
Adverse effect of other primarily systemic and hematological agents, initial encounter
- T45.8X5DBillable
Adverse effect of other primarily systemic and hematological agents, subsequent encounter
- T45.8X5SBillable
Adverse effect of other primarily systemic and hematological agents, sequela
- T45.8X6ABillable
Underdosing of other primarily systemic and hematological agents, initial encounter
- T45.8X6DBillable
Underdosing of other primarily systemic and hematological agents, subsequent encounter
- T45.8X6SBillable
Underdosing of other primarily systemic and hematological agents, sequela
- T45.95XABillable
Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
- T45.95XDBillable
Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
- T45.95XSBillable
Adverse effect of unspecified primarily systemic and hematological agent, sequela
- T45.96XABillable
Underdosing of unspecified primarily systemic and hematological agent, initial encounter
- T45.96XDBillable
Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter
